CNS & Neurological Disorders - Drug Targets
Title:ACKNOWLEDGEMENTS TO REVIEWERS
Volume: 15 Issue: 10
Export Options
About this article
Cite this article as:
ACKNOWLEDGEMENTS TO REVIEWERS, CNS & Neurological Disorders - Drug Targets 2016; 15 (10) . https://dx.doi.org/10.2174/187152731510161019000812
DOI https://dx.doi.org/10.2174/187152731510161019000812 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
21
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Curcumin and its Multi-target Function Against Pain and Inflammation: An Update of Pre-clinical Data
Current Drug Targets Psychological Treatments for Hypochondriasis: A Narrative Review
Current Psychiatry Reviews Oxidative and Non-Oxidative Metabolomics of Ethanol
Current Drug Metabolism ERRATUM
Current Alzheimer Research Synthesis, Biological Activity of Thiazolidinones Bearing Indoline Moiety and Isatin Based Hybrids
Mini-Reviews in Organic Chemistry Prion Disease: A Deadly Disease for Protein Misfolding
Current Pharmaceutical Biotechnology PIENSA: Development of an Early Intervention Program for Adolescents With Early-Onset Psychosis and Their Families
Adolescent Psychiatry Gang Involvement, Mental Health Difficulties and Exposure to Violence in 11-16-Year-Old School Students
Adolescent Psychiatry Chronic Pain: Cytokines, Lymphocytes and Chemokines
Inflammation & Allergy - Drug Targets (Discontinued) The Immunologic Barriers to Replacing Damaged Organs
Current Immunology Reviews (Discontinued) Targeting T-Cell Adhesion Molecules for Drug Design
Current Pharmaceutical Design Central Nervous System Acting Drugs in Treatment of Migraine Headache
Central Nervous System Agents in Medicinal Chemistry miR-132 Down-regulates Methyl CpG Binding Protein 2 (MeCP2) During Cognitive Dysfunction Following Chronic Cerebral Hypoperfusion
Current Neurovascular Research Receptor-Binding and Pharmacokinetic Properties of Dopaminergic Agonists
Current Topics in Medicinal Chemistry Modulation of the Peripheral and Central Inflammatory Responses by a-Melanocyte Stimulating Hormone
Current Protein & Peptide Science Neuroscience of Exercise: Association Among Neurobiological Mechanisms and Mental Health
CNS & Neurological Disorders - Drug Targets Chromones and their Derivatives as Radical Scavengers: A Remedy for Cell Impairment
Current Topics in Medicinal Chemistry From the Stretcher to the Pharmacys Shelf: Drug Leads from Medically Important Brazilian Venomous Arachnid Species
Inflammation & Allergy - Drug Targets (Discontinued) Autoimmunity and Frontotemporal Dementia
Current Alzheimer Research Meet Our Editor-in-Chief
CNS & Neurological Disorders - Drug Targets